AveXis, Inc. AVXS was a big mover last session, as the company saw its shares above 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up almost 88% in the past one-month time frame.
In the last 30 days, the company has seen one downward estimate revision and the Zacks Consensus Estimate also moved lower, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
AveXis currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked Bio-medical/Gene stock is ANI Pharmaceuticals, Inc. ANIP, which sports a Zacks Rank #1 (Strong Buy).
Is AVXS going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment